Reports.
Current and periodic reports of MedApp S.A. published via the ESPI and EBI systems
Disclosure obligations
As a company listed on the NewConnect market, MedApp S.A. fulfils its disclosure obligations through the ESPI and EBI systems. Below you will find a complete, regularly updated archive of our current and periodic reports — from financial results and general meeting resolutions to key business and regulatory developments. Use the filters or the search field to quickly find the report you are looking for; each entry links to its official publication.
Report archive
- Current reportsEvents with an impact on the Company
- Periodic reportsQuarterly and annual results
- Official sourcePublished via the ESPI and EBI systems
2015.Since
Report type
Category
Year
Search
- Periodic reportEBI
Report for Q2-2026
- Current reportESPI
List of shareholders holding at least 5% of the total votes at the Company's AGM on 29.06.2026
- Current reportEBI
Information on the General Meeting – content of the resolutions adopted by the GM (including information on an adjournment of the meeting)
- Current reportESPI
Supplement to the materials for the Annual General Meeting of MedApp S.A. with its registered office in Kraków convened for 29.06.2026
- Current reportEBI
Information on the General Meeting – convening of the GM with draft resolutions, changes to the GM agenda
- Current reportESPI
Announcement on convening the Company's Annual General Meeting for 29 June 2026 and draft resolutions
- Current reportEBI
Information on the General Meeting – convening of the GM with draft resolutions, changes to the GM agenda
- Periodic reportEBI
Consolidated annual report
- Periodic reportEBI
Annual report
- Periodic reportEBI
Quarterly report for Q1
- Current reportESPI
Conclusion of a distribution agreement on the Hungarian market
- Current reportESPI
Conclusion of a distribution agreement on the Thai market
- Current reportESPI
Termination of the agreement with the Social Insurance Institution (ZUS) in connection with the opening of the Company's restructuring proceedings
- Current reportESPI
Ruling on the discontinuation of the Issuer's bankruptcy proceedings
- Current reportESPI
Filing by a subsidiary of an application for a military licence
- Periodic reportEBI
Quarterly report for Q4
- Current reportESPI
Conclusion of a distribution agreement on the GCC markets
- Current reportESPI
Withdrawal of the petition for bankruptcy of MedApp S.A.
- Current reportESPI
Suspension by the Court of the examination of the bankruptcy petition
- Current reportESPI
Opening of accelerated arrangement proceedings against the Issuer
- Current reportEBI
Schedule of publication of periodic reports
- Current reportESPI
Conclusion by the Issuer of an agreement with the Social Insurance Institution (ZUS) on the repayment of debt
- Current reportESPI
Filing by the Issuer of a petition to the Court to open accelerated arrangement proceedings
- Current reportEBI
Entry concerning the Issuer's enterprise in Section 4 of the register of entrepreneurs
- Current reportESPI
Filing by a creditor of a petition for the Issuer's bankruptcy
- Periodic reportEBI
Issuer's periodic report for Q3 2025
- Current reportESPI
Filing of a provisional patent application in the USA (USPTO) concerning a system and method of surgical navigation in augmented reality
- Current reportESPI
Conclusion of a material agreement with SDS Optic S.A.
- Current reportESPI
Update of the information concerning the termination (withdrawal) of the project funding agreement
- Current reportEBI
Conclusion of an agreement with an Authorised Adviser regarding the introduction of series D, E, F and G shares to trading in the ATS on the NewConnect market
- Periodic reportEBI
Issuer's periodic report for Q2 2025
- Current reportEBI
Resolutions adopted at the Company's Annual General Meeting on 26 June 2025
- Current reportESPI
List of shareholders holding at least 5% of the total votes at the Company's AGM on 26.06.2025
- Current reportEBI
Resolutions adopted at the Company's Annual General Meeting on 26 June 2025
- Current reportEBI
Supplement to the materials for the Annual General Meeting of MedApp S.A. with its registered office in Kraków convened for 26.06.2025
- Current reportEBI
Announcement on convening the Company's Annual General Meeting for 26 June 2025 and draft resolutions
- Current reportESPI
Announcement on convening the Company's Annual General Meeting for 26 June 2025 and draft resolutions
- Periodic reportEBI
Consolidated annual report of MedApp S.A. for the financial year 2024
- Periodic reportEBI
Standalone annual report of MedApp S.A. for the financial year 2024
- Periodic reportEBI
Issuer's periodic report for Q1 2025
- Current reportEBI
Change of the publication date of the annual report for 2024
- Current reportEBI
Change of the publication date of the annual report for 2024
- Current reportESPI
Discontinuation of the proceedings for approval of the Company's Prospectus
- Periodic reportEBI
Issuer's periodic report for Q4 2024
- Current reportEBI
Dismissal of the commercial proxy (prokurent)
- Current reportEBI
Schedule for the publication of periodic reports in 2025
- Current reportEBI
Conclusion of an agreement with an audit firm
- Periodic reportEBI
Issuer's periodic report for Q3 2024
- Current reportESPI
Receipt of the MDR certificate for CarnaLife Holo and CarnaLife System
- Periodic reportEBI
Issuer's periodic report for Q2 2024
- Current reportESPI
List of shareholders holding at least 5% of the total votes at the Company's AGM on 26.07.2024
- Current reportEBI
Resolutions adopted at the Company's Annual General Meeting on 26 July 2024
- Current reportESPI
Signing of a funding agreement with the European Innovation Council and SMEs Executive Agency (EISMEA)
- Current reportESPI
Termination of the project funding agreement
- Current reportESPI
Conclusion of a transaction advisory agreement
- Current reportESPI
Announcement on convening the Company's Annual General Meeting for 26 July 2024 and draft resolutions
- Current reportEBI
Announcement on convening the Company's Annual General Meeting for 26 July 2024 and draft resolutions
- Periodic reportEBI
Consolidated annual report of MedApp S.A. for the financial year 2023
- Periodic reportEBI
Standalone annual report of MedApp S.A. for the financial year 2023
- Current reportEBI
Change of the publication date of the annual report for 2023
- Current reportESPI
Registration of the subsidiary Medapp USA Inc. based in the United States
- Periodic reportEBI
Issuer's periodic report for Q1 2024
- Current reportEBI
Change of the Issuer's registered office address
- Current reportEBI
Information on the application of the corporate governance principles 'Best Practices of Companies Listed on NewConnect 2024'
- Current reportESPI
Receipt of a notification under Art. 69 of the Act on Public Offering – increase in holding
- Current reportESPI
Receipt of a notification under Art. 69 of the Act on Public Offering – increase in holding
- Current reportESPI
Receipt of a notification under Art. 69 of the Act on Public Offering – decrease in holding
- Current reportESPI
Receipt of a notification under Art. 69 of the Act on Public Offering – decrease in holding
- Periodic reportEBI
Issuer's periodic report for Q4 2023
- Current reportEBI
Schedule for the publication of periodic reports in 2024
- Current reportESPI
Filing of a patent application by the company Medapp Radiotherapy Sp. z o.o.
- Current reportESPI
Signing of a funding agreement with the National Centre for Research and Development (NCBiR)
- Current reportESPI
Increase of share capital in the subsidiary MedApp Clinical Research Sp. z o.o.
- Periodic reportEBI
Correction of the periodic report for Q3 2023
- Periodic reportEBI
Periodic report for Q3 2023
- Current reportEBI
Appointment of a commercial proxy (prokurent)
- Current reportEBI
Resignation of the Vice-President of the Management Board
- Current reportEBI
Changes in the composition of the Management Board of MEDAPP Spółka Akcyjna
- Current reportESPI
List of shareholders holding at least 5% of the total votes at the Company's Extraordinary General Meeting on 25 September 2023
- Current reportEBI
Resolutions adopted at the Company's Extraordinary General Meeting on 25 September 2023
- Current reportESPI
Increase of share capital in the subsidiary MedApp Clinics Sp. z o.o
- Current reportESPI
Changes in the Management Board of a subsidiary of MedApp S.A.
- Current reportESPI
Announcement on convening the Company's Extraordinary General Meeting for 25 September 2023 and draft resolutions
- Current reportEBI
Announcement on convening the Company's Extraordinary General Meeting for 25 September 2023 and draft resolutions
- Current reportEBI
Change in the Management Board of MedApp S.A. with its registered office in Kraków
- Periodic reportEBI
Consolidated periodic report for Q2 2023
- Current reportESPI
Signing of an investment agreement by the subsidiary MedApp Clinics Sp. z o.o.
- Current reportESPI
Changes in the Management Boards of subsidiaries of MedApp S.A.
- Current reportESPI
List of shareholders holding at least 5% of the total votes at the Company's AGM on 27.07.2023
- Current reportEBI
Resolutions adopted at the Company's General Meeting on 27 July 2023
- Current reportEBI
Changes in the Supervisory Board of MedApp S.A. with its registered office in Kraków
- Current reportEBI
Announcement of an adjournment of the AGM until 27 July 2023
- Current reportEBI
Appointment of Mr Krzysztof Mędrala as President of the Management Board of MedApp S.A.
- Current reportESPI
Increase of share capital in the subsidiary MedApp Clinics Sp. z o.o.
- Current reportEBI
Supplement to the materials for the Annual General Meeting of MedApp S.A.
- Current reportESPI
Increase of share capital in the subsidiary MedApp AI Sp. z o.o.
- Current reportEBI
Management Board's motion of MedApp S.A. on the distribution of profit for 2022
- Current reportESPI
Announcement on convening the Company's Annual General Meeting
- Current reportEBI
Announcement on convening the Company's Annual General Meeting
- Current reportESPI
Increase of share capital in the subsidiary MedApp RT Sp. z o.o.
- Periodic reportEBI
Consolidated annual report of MedApp S.A. for the financial year 2022
- Periodic reportEBI
Standalone annual report of MedApp S.A. for the financial year 2022
- Current reportESPI
Registration of the subsidiary – MedApp AI Sp. z o.o. based in Rzeszów
- Periodic reportEBI
Consolidated periodic report for Q1 2023
- Current reportESPI
Registration of the subsidiary – MedApp Clinics Sp. z o.o. based in Rzeszów
- Current reportESPI
First registration of CarnaLife Holo by the Food and Drug Administration
- Current reportESPI
Establishment of subsidiaries – MedApp AI and MedApp Clinics
- Current reportESPI
List of shareholders holding at least 5% of the total votes
- Current reportEBI
Resolutions adopted at the Company's Extraordinary General Meeting
- Current reportEBI
Changes in the Supervisory Board of MedApp S.A. with its registered office in Kraków
- Current reportESPI
Signing of an agreement with TÜV NORD Polska for the recertification of medical devices
- Current reportESPI
Granting of a new exclusive licence for the RIS Software
- Current reportEBI
Information on an incidental breach of the obligation to publish a current report
- Current reportEBI
Conclusion of an agreement with an audit firm
- Current reportESPI
Announcement on convening the Company's Extraordinary General Meeting
- Current reportEBI
Announcement on convening the Company's Extraordinary General Meeting
- Current reportESPI
Review of strategic options
- Periodic reportEBI
Consolidated periodic report for Q4 2022
- Current reportESPI
Correction of current report No. 30/2022 of 30 December 2022
- Current reportESPI
Notification of the conclusion of an agreement to dispose of the company's subscription warrants by a person discharging managerial responsibilities at MedApp S.A.
- Current reportESPI
Information on the conclusion of an insurance agreement by MedApp S.A. with Chubb European Group SE Spółka Europejska Oddział w Polsce
- Current reportEBI
Schedule for the publication of periodic reports in 2023
- Current reportESPI
Notification of the conclusion of an agreement to take up series C warrants by a person discharging managerial responsibilities at MedApp S.A.
- Current reportESPI
Conclusion of a distribution agreement with TND LLP based in Almaty (Kazakhstan)
- Current reportESPI
Information on the indirect acquisition of the Company's shares
- Current reportESPI
Registration of the subsidiary – MedApp RT Sp. z o.o. based in Kraków
- Current reportESPI
Conclusion of a distribution agreement with LIVARTIX SRL based in Bucharest (Romania)
- Current reportESPI
Establishment of the subsidiary – MedApp RT Sp. z o.o. in organisation, based in Kraków
- Current reportESPI
Conclusion of an annex to the subcontracting agreements for part of the software and design work 'Radiology Information System (RIS)' with JellyTech Sp. z o.o. based in Warsaw
- Periodic reportEBI
Company's periodic report for Q3 2022
- Current reportESPI
Termination of the advisory services agreement with Haitong Bank, S.A. based in Lisbon dated 31 March 2022
- Current reportESPI
Registration of the word marks CarnaLife Holo and CarnaLife System in the European Union Trade Marks Register
- Current reportEBI
Registration of amendments to the articles of association of MEDAPP Spółka Akcyjna
- Current reportESPI
Expiry of the exclusivity right regarding the distribution agreement with Medical Idea Spółka z ograniczoną odpowiedzialnością based in Łódź
- Periodic reportEBI
Company's periodic report for Q2 2022
- Current reportEBI
Supplement to EBI current report No. 25/2020 of 6.08.2020
- Current reportESPI
List of shareholders holding at least 5% of the total votes at the Company's AGM on 29.06.2022
- Current reportEBI
Resolutions adopted at the Company's AGM on 29 June 2022
- Current reportESPI
Submission of the CarnaLife Holo product application to the U.S. Food and Drug Administration (FDA)
- Current reportESPI
Conclusion of a cooperation agreement setting out the licence terms for the CarnaLife Holo System with AWP P_C Spółka Akcyjna Oddział w Polsce based in Warsaw
- Current reportEBI
Supplement to the materials for the Annual General Meeting of MedApp S.A. with its registered office in Kraków convened for 29.06.2022
- Current reportEBI
Announcement on convening the Company's Annual General Meeting for 29 June 2022 and draft resolutions
- Current reportESPI
Announcement on convening the Company's Annual General Meeting for 29 June 2022 and draft resolutions
- Current reportESPI
Management Board's motion of MedApp S.A. on the distribution of profit for 2021
- Current reportESPI
Receipt of certification for the CarnaLife Holo product on the market of the Federative Republic of Brazil
- Periodic reportEBI
Company's periodic report for Q1 2022
- Current reportESPI
Conclusion of a distribution agreement with PROMEDICA PRAHA GROUP a.s. based in Prague (Czech Republic)
- Periodic reportEBI
Issuer's annual report for the financial year 2021
- Current reportESPI
Filing of an application to confirm the conformity of the CarnaLife Holo product with the legal requirements applicable on the market of the Federative Republic of Brazil
- Current reportESPI
Filing by MedApp S.A. based in Kraków of an application to introduce bearer shares of series D, E, F and G to trading on the NewConnect market
- Current reportESPI
Conclusion of an advisory services agreement with HAITONG BANK, S.A. based in Lisbon
- Current reportESPI
Conclusion of a subcontracting agreement for part of the software and design work 'Radiology Information System (RIS)'
- Current reportESPI
Change in the holding of the Issuer's shares by Inventionmed S.A. based in Bydgoszcz
- Current reportESPI
Report on filing with the Polish Financial Supervision Authority (KNF) an application for a temporary suspension of the proceedings
- Current reportEBI
Information on an incidental breach of the obligation resulting from the postponement of the publication date of the annual report for 2021
- Periodic reportEBI
Company's periodic report for Q4 2021
- Current reportEBI
Information on the conclusion of an Authorised Adviser services agreement with Prosper Capital Dom Maklerski S.A.
- Current reportEBI
Change of the schedule for the publication of periodic reports in 2022
- Current reportESPI
Establishment of a subsidiary of MedApp S.A. – MedApp Germany GmbH based in Düsseldorf
- Current reportESPI
Conclusion of a Project Funding Agreement under the Smart Growth Operational Programme
- Current reportEBI
Schedule for the publication of periodic reports in 2022
- Current reportESPI
Conclusion of an agreement for the development of the 'Radiology Information System (RIS)'
- Current reportESPI
Change in the holding of the Issuer's shares
- Current reportESPI
Shareholder's notification of exceeding the 5% threshold of the Issuer's shares
- Current reportESPI
Conclusion of an insurance agreement
- Current reportEBI
Conclusion of an agreement with an audit firm
- Current reportESPI
Correction of EBI current report No. 24/2019 of 28 November 2019
- Periodic reportEBI
Periodic report on the Issuer's operations for Q3 2021
- Current reportEBI
Supplement to current report 25/2019 of 20 December 2019
- Current reportEBI
Change of the publication date of the Issuer's periodic report for Q3 2021
- Periodic reportEBI
Periodic report on the Issuer's operations for Q2 2021
- Current reportEBI
Change of the publication date of the Issuer's periodic report for Q2 2021
- Current reportEBI
Change of the Issuer's registered office address
- Current reportESPI
Introduction of the Issuer's shares to trading on the market in Germany
- Current reportESPI
List of shareholders holding at least 5% of the total votes at the Company's AGM on 29.06.2021
- Current reportEBI
Appointment of a new member of the Supervisory Board
- Current reportEBI
Resolutions adopted at the Company's AGM on 29 June 2021
- Current reportESPI
Introduction of the Issuer's shares to trading on Börse Frankfurt
- Current reportESPI
Announcement on convening the Company's Annual General Meeting for 29 June 2021 and draft resolutions
- Current reportESPI
Conclusion of a distribution agreement with Medical Idea Spółka z ograniczoną odpowiedzialnością based in Łódź
- Current reportESPI
Conclusion of a distribution agreement with FP Business SAS based in Lupcourt (France)
- Current reportESPI
Conclusion by MedApp S.A. of a consortium agreement regarding the DECODE project under the EU Marie Skłodowska-Curie – Horizon 2020 programme
- Current reportESPI
Estimated selected financial data of the Issuer for 2020
- Current reportESPI
Conclusion of a cooperation agreement with Diagnostyka Sp. z o.o. based in Kraków
- Current reportESPI
Fifth call to the Company's shareholders to submit the Company's share documents for their dematerialisation
- Current reportESPI
Conclusion by MedApp S.A. and Insight Direct Limited of a partnership agreement for the commercialisation in the United Kingdom of the CarnaLife Holo and SurgeonEye software
- Current reportESPI
Conclusion of an insurance agreement
- Current reportESPI
Receipt by MedApp S.A. of the Mixed Reality Distributor – Managed Partner (DMP) status from Microsoft
- Current reportESPI
Admission of MedApp S.A. to the Microsoft Mixed Reality Partner Program (MRPP) as a Silver Partner
- Current reportESPI
List of shareholders holding at least 5% of the total votes at the EGM on 30.12.2020
- Current reportESPI
Extension of the EGM agenda at the request of a Company shareholder
- Current reportESPI
Announcement on convening the Extraordinary General Meeting for 30 December 2020
- Current reportESPI
Fourth call to the Company's shareholders to submit the Company's share documents for their dematerialisation
- Current reportESPI
Pilot implementation agreement for the CarnaLife System application at Diabdis Sp. z o.o.
- Current reportESPI
Signing of a licence agreement for the implementation of the CarnaLife System application
- Current reportESPI
Third call to the Company's shareholders to submit the Company's share documents for their dematerialisation
- Current reportESPI
Signing of an implementation agreement for the CarnaLife System application
- Current reportESPI
Acquisition of the Issuer's shares by a supervising person
- Periodic reportEBI
Supplement to the periodic report for Q3 2020
- Periodic reportEBI
Periodic report on the Issuer's operations for Q3 2020
- Current reportEBI
Change of the publication date of the report for Q3 2020
- Current reportESPI
Second call to the Company's shareholders to submit the Company's share documents for their dematerialisation
- Current reportESPI
Call to the Company's shareholders to submit the Company's share documents for their dematerialisation
- Current reportESPI
Conclusion of a cooperation agreement with Pozitive.dev under the Tumor3D project
- Current reportEBI
Changes in the composition of the Issuer's Management Board
- Current reportESPI
Signing of an agreement for the implementation of the IP BOX tax solution
- Periodic reportEBI
Correction of the periodic report for Q2 2020
- Periodic reportEBI
Periodic report for Q2 2020
- Current reportESPI
Signing of a distribution agreement with WLOG Solutions Sp. z o.o.
- Current reportESPI
Signing of a pilot implementation agreement for the CarnaLife System
- Current reportESPI
List of shareholders holding at least 5% of the total votes at the AGM on 05.08.2020
- Current reportEBI
Appointment of Supervisory Board members for a new term of office
- Current reportEBI
Resolutions adopted at the Company's AGM on 5 August 2020
- Current reportEBI
Filing with the Polish Financial Supervision Authority (KNF) of an application for approval of the prospectus
- Periodic reportEBI
Correction of the periodic report for Q1 2020
- Periodic reportEBI
Correction of the periodic report for Q1 2019
- Current reportESPI
Signing of an agreement by MedApp S.A. with Parexel International for advisory services on the FDA certification of the CarnaLife Holo application
- Current reportESPI
Announcement on convening the Annual General Meeting for 5 August 2020 and draft resolutions
- Current reportEBI
Announcement on convening the Annual General Meeting for 5 August 2020 and draft resolutions
- Current reportESPI
Change in a shareholder's stake in connection with the increase of the Issuer's share capital
- Current reportESPI
Pilot implementation agreement for CarnaLife System with CARINTART Sp. z o.o.
- Current reportESPI
Signing of an agreement for the use of the CarnaLife telemedicine system
- Current reportESPI
Notification of the acquisition of the Issuer's shares by a managing person
- Current reportESPI
Notification of the acquisition of the Issuer's shares and exercise of warrant rights by a supervising person
- Current reportEBI
Taking up of shares under the Issuer's registered conditional capital
- Periodic reportEBI
Supplement to the annual report of 30 June 2020
- Current reportESPI
List of shareholders holding at least 5% of the total votes at the EGM on 29.06.2020
- Periodic reportEBI
Issuer's annual report for the financial year 2019
- Current reportEBI
Resolutions adopted at the Company's EGM on 29 June 2020
- Current reportEBI
Change of the publication date of the Company's annual report
- Current reportESPI
Sales agreement for the CarnaLife System application
- Current reportESPI
Signing of an agreement for the use of the CarnaLife Holo system with the NEO Hospital Sp. z o.o. ONE Spółka komandytowa hospital
- Current reportESPI
Renewal of the certification of the CarnaLife telemedicine system
- Current reportESPI
List of shareholders holding at least 5% of the total votes at the EGM on 08.06.2020
- Current reportEBI
Resolutions adopted at the Company's EGM on 8 June 2020
- Current reportESPI
Announcement on convening the Extraordinary General Meeting for 29 June 2020 and draft resolutions
- Current reportEBI
Announcement on convening the Extraordinary General Meeting for 29 June 2020 and draft resolutions
- Current reportEBI
Change of the publication date of the Company's annual report
- Periodic reportEBI
Periodic report for Q1 2020
- Current reportESPI
Announcement on convening the Extraordinary General Meeting for 8 June 2020 and draft resolutions
- Current reportEBI
Announcement on convening the Extraordinary General Meeting for 8 June 2020 and draft resolutions
- Current reportESPI
Sale of shares in related entities
- Current reportESPI
Signing of a legal advisory agreement in connection with the Issuer's plan to move to the main market of the Warsaw Stock Exchange (GPW)
- Current reportEBI
Signing of an agreement for the supply of a 3D DICOM image visualisation system
- Current reportEBI
Signing of an agreement with a statutory auditor
- Current reportEBI
Completion of the subscription for the Issuer's series G shares
- Current reportESPI
Winning a tender for the supply of a 3D medical imaging data visualisation system
- Periodic reportEBI
Quarterly report for Q4 2019
- Current reportESPI
Publication of the offering document in connection with the public offering of the Issuer's series G shares
- Current reportEBI
Correction of current report No. 27/2019 of 30 December 2019
- Current reportEBI
Schedule for the publication of periodic reports in 2020
- Current reportEBI
Appointment of a member of the Issuer's Supervisory Board
- Current reportESPI
Notification of the acquisition of the Issuer's shares by a managing person
- Current reportEBI
Conclusion of sales agreements on the US market
- Current reportESPI
Change in the holding of the Issuer's shares
- Current reportESPI
Change in the holding of the Issuer's shares
- Current reportESPI
Change in the holding of the Issuer's shares
- Current reportEBI
Increase of the Issuer's share capital
- Current reportEBI
Resignation of a member of the Supervisory Board
- Current reportEBI
Changes in the composition of the Company's Management Board
- Current reportEBI
Signing of an agreement to acquire the company Medapp LLC
- Periodic reportEBI
Correction of the periodic report for Q3 2019
- Periodic reportEBI
Periodic report for Q3 2019
- Current reportEBI
Signing of a letter of intent with Glocal Health AB
- Current reportESPI
List of shareholders holding at least 5% of the total votes at the EGM on 07.10.2019
- Current reportEBI
Content of the resolutions adopted at the Issuer's Extraordinary General Meeting of Shareholders on 07.10.2019
- Current reportEBI
Appointment of a member of the Issuer's Supervisory Board
- Current reportEBI
Resignation from the position of member of the Issuer's Supervisory Board
- Current reportEBI
Signing of a cooperation agreement with Johnson & Johnson Poland Sp. z o.o.
- Current reportEBI
Announcement on convening the Extraordinary General Meeting of Shareholders of Medapp S.A. for 7 October 2019
- Periodic reportEBI
Periodic report for Q2 2019
- Current reportEBI
Receipt of funding under the Polish Technological Bridges programme
- Current reportESPI
List of shareholders who took part in the General Meeting and held at least 5% of the votes
- Current reportEBI
Termination of the agreement by the Authorised Adviser
- Current reportEBI
Resignation of a managing person
- Current reportEBI
Changes in the composition of the Supervisory Board of Medapp Spółka Akcyjna
- Current reportEBI
Content of the resolutions adopted at the Annual General Meeting of Shareholders on 27.06.2019
- Current reportESPI
Receipt of a notification of a change in the share in the total number of the Issuer's votes
- Current reportESPI
Receipt of a notification of a change in the share in the total number of the Issuer's votes
- Current reportESPI
Receipt of a notification of a change in the share in the total number of the Issuer's votes
- Current reportESPI
Announcement on convening the Annual General Meeting for 27 June 2019 together with draft resolutions
- Current reportEBI
Announcement on convening the Annual General Meeting for 27 June 2019 together with draft resolutions
- Periodic reportEBI
Annual report of Medapp S.A. for 2018
- Current reportEBI
Correction of the report: Supplement to report 5/2019 – Dismissal of a member of the management body and appointment of a managing person
- Current reportEBI
Supplement to report 5/2019 – Dismissal of a member of the management body and appointment of a managing person
- Current reportEBI
Dismissal of a member of the management body and appointment of a managing person
- Periodic reportEBI
Periodic report for Q1 2019
- Current reportESPI
Receipt of corrections to notifications from shareholders
- Current reportESPI
Signing of an agreement for the distribution of the CarnaLife system
- Current reportESPI
Receipt of a correction to notifications from shareholders
- Periodic reportEBI
Correction of the periodic report for Q4 2018
- Periodic reportEBI
Periodic report for Q4 2018
- Current reportEBI
Dates for the publication of periodic reports in 2019
- Current reportESPI
Receipt of notifications from shareholders
- Current reportESPI
Receipt of notifications from shareholders
- Current reportEBI
Taking up of series F shares under the conditional capital
- Current reportESPI
UHY ECA – Signing of an agreement for the audit of the financial statements of MEDAPP S.A.
- Current reportEBI
Signing of an agreement with a statutory auditor
- Current reportEBI
Supplement to report 16/2018 – Appointment of a member of the Supervisory Board
- Periodic reportEBI
Periodic report for Q3 2018
- Current reportEBI
Supplement to report 18/2018 – Appointment of a member of the Management Board
- Current reportEBI
Appointment of a member of the Management Board
- Current reportEBI
Appointment of a new member of the Management Board
- Current reportEBI
Appointment of new members of the Supervisory Board
- Current reportEBI
Resignation of a member of the Supervisory Board
- Current reportEBI
Resignation of a supervising person
- Current reportESPI
Information on the performance of the cooperation agreement with the European Health Centre Otwock
- Periodic reportEBI
Periodic report for Q2 2018
- Current reportESPI
Correction of ESPI report 14/2018
- Current reportESPI
Conclusion of a letter of intent with the Medical University of Warsaw
- Current reportESPI
Signing of a letter of intent with Intec Medical Sp. z o.o.
- Current reportESPI
Signing of a consortium agreement of which the Issuer is a member
- Current reportEBI
Professional CV of a new member of the Supervisory Board
- Current reportEBI
Appointment of a new member of the Supervisory Board
- Current reportEBI
Resignation of a supervising person
- Current reportESPI
Conclusion of a letter of intent with Future Processing
- Current reportESPI
List of shareholders who took part in the General Meeting and held at least 5% of the votes
- Current reportEBI
The AGM's decision to abstain from voting on item 8g of the agenda
- Current reportEBI
Content of the resolutions adopted at the Annual General Meeting on 28.06.2018
- Current reportESPI
Appointment of the Scientific Council
- Current reportESPI
Selection of the offer of the consortium of which the Issuer is a member
- Current reportESPI
Announcement on convening the AGM for 28 June 2018
- Current reportEBI
Announcement on convening the AGM for 28 June 2018
- Periodic reportEBI
Annual report for 2017
- Periodic reportEBI
Periodic report for Q1 2018
- Current reportESPI
Receipt of notifications from shareholders – correction
- Current reportESPI
Receipt of notifications from shareholders
- Current reportEBI
Conclusion of agreements to take up series B subscription warrants
- Current reportESPI
Receipt of a notification of a change in the previously held share in the votes
- Current reportESPI
Conclusion of a letter of intent
- Current reportESPI
Receipt of notifications of a change in the share in the total number of the Issuer's votes
- Periodic reportEBI
Periodic report for Q4 2017
- Current reportEBI
Correction of report No. 1/2018
- Current reportEBI
Dates for the publication of periodic reports in 2018
- Current reportESPI
Correction of ESPI report 1/2018
- Current reportESPI
Conclusion of a material agreement
- Current reportESPI
Notifications under Art. 69 of the Act on Public Offering – change of a stake exceeding 33% of the total votes by at least 1%
- Current reportESPI
UHY ECA – Signing of an agreement for the audit of the financial statements of MEDAPP S.A.
- Current reportEBI
Signing of an agreement with a statutory auditor
- Current reportESPI
Conclusion of material agreements together with updating information
- Current reportESPI
Conclusion of an agreement to acquire shares in Telemedica Sp. z o.o.
- Periodic reportEBI
Periodic report for Q3 2017
- Current reportESPI
Signing of a letter of intent
- Current reportEBI
Registration of the conditional increase of share capital
- Current reportESPI
Signing of a letter of intent
- Current reportESPI
List of shareholders who took part in the General Meeting and held at least 5% of the votes
- Current reportESPI
Signing of an agreement with the Medical University in Astana
- Current reportEBI
Content of the resolutions adopted at the Extraordinary General Meeting of Shareholders on 28.09.2017
- Current reportESPI
Negotiations regarding a telemedicine project in Kazakhstan
- Current reportESPI
Announcement on convening the Extraordinary General Meeting for 28 September 2017 together with draft resolutions
- Current reportEBI
Announcement on convening the Extraordinary General Meeting for 28 September 2017 together with draft resolutions
- Current reportESPI
Receipt of funding from Microsoft
- Periodic reportEBI
Periodic report for Q2 2017
- Current reportESPI
List of shareholders who took part in the General Meeting and held at least 5% of the votes
- Current reportEBI
Changes in the composition of the Supervisory Board
- Current reportEBI
Content of the resolutions adopted at the Annual General Meeting of Shareholders on 30.06.2017
- Current reportESPI
Obtaining the CE certificate for the CarnaLife telemedicine system
- Current reportESPI
Announcement on convening the Annual General Meeting for 30 June 2017 together with draft resolutions
- Current reportEBI
Announcement on convening the Annual General Meeting for 30 June 2017 together with draft resolutions
- Periodic reportEBI
Annual report of MedApp S.A. for 2016
- Periodic reportEBI
Periodic report for Q1 2017
- Current reportESPI
Receipt of a correction to the notification of a change in the previously held share in the votes
- Current reportESPI
Notification of a change in the previously held share in the votes
- Current reportESPI
Notification of a change in the previously held share in the votes
- Current reportESPI
Notification of a change in the previously held share in the votes
- Current reportEBI
Taking up of series E shares under the conditional capital
- Current reportESPI
UHY ECA – Signing of an agreement for the audit of the financial statements of MEDAPP S.A.
- Current reportEBI
Signing of an agreement with a statutory auditor
- Periodic reportEBI
Correction of quarterly report No. 2/2017
- Periodic reportEBI
Periodic report for Q4 2016
- Current reportEBI
Dates for the publication of periodic reports in 2017
- Current reportESPI
Signing of a funding agreement under the 'International Activity of Małopolska SMEs' programme
- Current reportESPI
Information on transactions in shares
- Current reportESPI
Receipt of funding under the 'International Activity of Małopolska SMEs' programme
- Periodic reportEBI
Periodic report for Q3 2016
- Current reportEBI
Resignation of a member of the Supervisory Board
- Periodic reportEBI
Periodic report for Q2 2016
- Current reportEBI
Conclusion of an agreement with an Authorised Adviser
- Current reportESPI
List of shareholders who took part in the GM and held at least 5% of the votes
- Current reportEBI
Changes in the composition of the Supervisory Board
- Current reportEBI
Content of the resolutions adopted at the AGM on 30.06.2016
- Periodic reportEBI
Consolidated annual report for 2015
- Current reportEBI
Announcement on convening the Annual General Meeting for 30 June 2016 together with draft resolutions
- Current reportESPI
Announcement on convening the Annual General Meeting for 30 June 2016 together with draft resolutions
- Periodic reportEBI
Standalone annual report for 2015
- Periodic reportEBI
Standalone quarterly report for Q1 2016
- Current reportEBI
Change of the publication dates of the periodic reports for Q1, Q2 and Q3 2016
- Current reportESPI
Notification of a change in the share in the share capital and votes
- Current reportEBI
Registration in the National Court Register (KRS) of the change of the Issuer's registered office
- Current reportEBI
Change of the abbreviated name and share designation
- Current reportEBI
ECA – Selection of the company for the audit of the financial statements of MedApp S.A.
- Current reportEBI
Information on the merger of the Issuer with the company Medapp sp. z o.o. and the change of the Issuer's name
- Current reportESPI
YELLOW HAT – Second notification to the Issuer's shareholders of the intention to merge with the subsidiary MedApp Sp. z o.o.
- Current reportEBI
YELLOW HAT – Second notification to the Issuer's shareholders of the intention to merge with the subsidiary MedApp Sp. z o.o.
- Current reportESPI
YELLOW HAT – First notification to the Issuer's shareholders of the intention to merge with the subsidiary MedApp Sp. z o.o.
- Current reportEBI
YELLOW HAT – First notification to the Issuer's shareholders of the intention to merge with the subsidiary MedApp Sp. z o.o.
- Current reportEBI
YELLOW HAT – Agreement and signing of the merger plan of the Issuer with the subsidiary MedApp Sp. z o.o.
- Current reportEBI
YELLOW HAT – Decision on the intention to merge the Issuer with the subsidiary MedApp Sp. z o.o.
